| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |